Anemia treatment after hip or knee replacement
Part of Blood & lymphatic clinical trials.
This trial tests an oral medication, SSS17, for treating anemia that commonly occurs after hip or knee replacement surgery. It may help you recover by improving your red blood cell levels without needing a blood transfusion.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You are scheduled for hip or knee replacement surgery.
- You have mild to moderate anemia (hemoglobin between 80-110 g/L) before surgery.
- You do not have blood clots in your legs (confirmed by ultrasound).
- You are willing to use effective birth control during the trial.
- You do not have other causes of anemia, serious heart disease, or active infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new medicine called HS-20106 to see if it can improve anemia (low red blood cells) for people with certain types of MDS. If it works, it might reduce the need for blood transfusions.
This study tests a new injection called SRSD107 to see if it prevents blood clots after knee replacement surgery, compared to a standard blood thinner (enoxaparin). It might be an option if you are having a planned knee replacement and are otherwise healthy.
This trial tests whether an experimental capsule (H001) can prevent dangerous blood clots after knee replacement surgery. It is for people who are scheduled for a first-time total knee replacement and are willing to take the study drug instead of standard blood thinners.
This trial tests a new oral medicine (AND017) for people on dialysis who have anemia (low red blood cells). It may help reduce the need for injections of standard anemia medicines.
This study tests a shorter course of blood thinner medication (rivaroxaban) after hip replacement surgery, following an enhanced recovery plan. It aims to see if a shorter treatment can safely prevent blood clots and help you recover faster.
This study measures how a medicine called tranexamic acid (which helps reduce bleeding) works when given through a needle in the bone versus in a vein during hip or knee replacement surgery. It may help your surgeon choose the best way to control bleeding during your operation.
Hear when a new Arthroplasty, Replacement, Hip trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.